← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Guaifenesin + dextromethorphan (Creative Science Cough Tablets)

Updated October 26, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

A combination expectorant and cough suppressant marketed by Creative Science for dogs and cats. The manufacturer sheet lists guaifenesin 100 mg and dextromethorphan hydrobromide 10 mg per tablet.

Expectorant + centrally acting antitussiveProduct-specific clinical reference

Temporary symptom relief does not identify the cause of a cough. Confirm the exact combination before prescribing.

Key prescribing checks

  • The manufacturer sheet is not a comprehensive veterinary safety monograph or evidence of regulatory approval.
  • Human dextromethorphan labeling warns about antidepressant interactions and persistent or secretion-heavy cough; veterinary applicability requires assessment.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Dogs and cats

Manufacturer-described use; regulatory approval not established by reviewed sources

Temporary relief of cough symptoms

This is the Creative Science combination, not a synonym for every cough medicine.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Guaifenesin is the expectorant component; dextromethorphan is the cough-suppressant component.

Absorption, distribution, metabolism and elimination

Canine and feline pharmacokinetics for this specific combination were not established by the reviewed manufacturer sheet.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Creative Science Cough Tablets

Manufacturer canine/feline product sheet; human dextromethorphan warnings are identified separately.

Contraindications · when not to use

  • A comprehensive product-specific contraindication list is not provided by the manufacturer sheet.

Precautions & monitoring

  • Persistent or productive cough needs diagnosis; human dextromethorphan labeling cautions about excessive secretions. This is not a species-validated exclusion for this product.

Absence of a manufacturer safety restriction does not establish safety.

Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

A comprehensive animal adverse-effect profile is not supplied. Human dextromethorphan information describes neurologic and gastrointestinal effects; animal frequency is not established.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.

The manufacturer sheet uses small/large animal categories without defining weight boundaries. A patient-specific veterinary regimen has not been entered; confirm the package and prescribing plan.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Compare with other medications and check species →

Creative Science Cough Tablets

Manufacturer canine/feline product sheet; human dextromethorphan warnings are identified separately.

  • Human dextromethorphan labeling restricts MAO inhibitors and antidepressant combinations; veterinary review is required.
Interaction source ↗Interaction source ↗

Monitoring

Assess breathing, cough progression, treatment response and neurologic changes.

Client counseling

Do not substitute another cold/cough product or add an antidepressant without veterinary review. Breathing difficulty warrants urgent care.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Follow the current container for storage, expiry and handling.

Brands, formulations & ingredient identity

Active ingredients

Guaifenesin · Dextromethorphan hydrobromide

Other searchable names: Creative Science · Creative Science Cough Tablets · Cough Tablets · Cough tabs · Guaifenesin dextromethorphan · Dextromethorphan guaifenesin

Confirm this exact strength and full ingredient panel on the current package; other cough products are not automatically equivalent.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Creative Science Cough Tablets

Formulation
Oral tablets: guaifenesin 100 mg + dextromethorphan HBr 10 mg per tablet
Label / product scope
Dogs · Cats

Manufacturer-specific combination; verify the current package.

Product label / source ↗

References & review status

Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

Search another medication or supplement →

CONTINUE EXPLORING

Use these connected guides to prepare informed questions for your veterinary team.

Find Veterinary Care Near YouLocate general practices, urgent-care clinics, emergency hospitals and specialists.Read resource →When It Is an EmergencyRecognize signs that require immediate veterinary care.Read resource →Interactive Symptom NavigatorStart with what you notice and understand when to seek help.Read resource →Poisons and Household HazardsRecognize common exposures and avoid unsafe home treatment.Read resource →Printable Owner ToolkitBring observations, medication details and questions to your appointment.Read resource →
Privacy & cookie choices